Delivery Order 36F79722D0128-36C25724N0385
- This is a delivery order awarded by the U.S. Department of Veterans Affairs (VA) to Roche Diagnostics Corporation, doing business as Roche Diagnostics Corp, for the provision of ACCU CHEK medical equipment and supplies. The contract has a ceiling value of $10,519.60 and a completion date of September 29, 2025. The contract was awarded on December 18, 2024 and is a firm fixed price Delivery Order under Roche's existing General Services Administration (GSA) Schedule contract for in vitro...
- Roche Diagnostics Corporation has been awarded a delivery order valued at $12,606.12 for Accu-Chek testing supplies to support the Veterans Integrated Service Network 5, a civilian healthcare component of the Department of Veterans Affairs. This firm fixed price contract is scheduled for completion by November 3, 2025, and will be performed in Castleton, Indiana. The award was made without any set-aside designation, reflecting open competition in the federal marketplace. This delivery order is...
- This is a delivery order awarded to Roche Diagnostics Corporation by the Veterans Integrated Service Network 17 of the U.S. Department of Veterans Affairs (VA). The contract is for the provision of Accu-Chek brand blood glucose strips and controls under the VA's General Services Administration (GSA) Schedule 65-VII for in vitro diagnostics, reagents, and tests. The contract has a firm fixed price, a ceiling value of $287,713.26, and a performance period ending on May 31, 2024. Roche...
- This federal contract award was issued by the Defense Health Agency (DHA) to Roche Diagnostics Corporation, a leading manufacturer and distributor of in vitro diagnostics, reagents, and laboratory instruments. The $279,133.32 firm-fixed-price delivery order is for ACCU-CHEK INFORM II TEST STRIPS under the In Vitro Diagnostics, Reagents, Test (FSS-65-VII) General Services Administration (GSA) Schedule contract. This delivery order does not have a set-aside designation, indicating Roche...
- Roche Diagnostics Corporation was awarded a $77,498 firm fixed-price delivery order by the Department of Veterans Affairs' Veterans Integrated Service Network 10 for ACCU-CHEK and CoaguCHEK diagnostic products. This contract, which became effective on October 1, 2022, represents a decrease of $81.20 from a prior award and will be completed by September 30, 2027. The delivery order was issued under the parent In Vitro Diagnostics, Reagents, Test (FSS-65-VII) GSA Schedule contract, which...
- This firm-fixed-price purchase order was awarded by the Department of Veterans Affairs (VA) to Roche Diabetes Care Inc. for $494,383.68. The award is not a set-aside contract. Roche Diabetes Care Inc. is a leading manufacturer of diabetes management products, including blood glucose monitors, insulin pumps, and other Accu-Chek solutions. Through this contract, Roche will provide the VA with a variety of diabetic testing supplies, reagents, and laboratory materials to support healthcare...
- This federal contract award to Roche Diagnostics Corporation, a manufacturer and distributor of in vitro diagnostics, is a Delivery Order valued at $100,815.00 placed against an existing Indefinite Delivery Contract (IDC) under the Veterans Affairs (VA) General Services Administration (GSA) Schedule for In Vitro Diagnostics, Reagents, and Test Kits (FSS-65-VII). The contract is to provide RALS (Roche Accutrend Link System) CoaguChek products and services to the VA's Integrated Service Network...
- This federal contract award, with an ID of 36C25022P0070, was made by the Veterans Integrated Service Network 10 (VISN 10) of the Department of Veterans Affairs (VA) to Roche Diagnostics Corporation, a manufacturer and distributor of in vitro diagnostics and related laboratory equipment and supplies. The $12,551.60 firm fixed-price purchase order is for ACCU-CHEK products, with a period of performance through September 30, 2022. Roche Diagnostics has a history of providing critical care...
- This federal contract award is for a Point of Care Glucose Test, awarded by the Department of Veterans Affairs Veterans Health Administration to Roche Diagnostics Corporation. The contract is a Blanket Purchase Agreement (BPA) Call under Roche's General Services Administration (GSA) Schedule 65-VII for In Vitro Diagnostics, Reagents, and Test Kits. The potential value of the contract is $20,766.24, and it has a completion date of September 30, 2024. Roche Diagnostics, a manufacturer and...
- This $297,244.05 firm fixed price delivery order contract was awarded by the Veterans Integrated Service Network 6 (VISN 6) of the U.S. Department of Veterans Affairs to Roche Diagnostics Corporation, a manufacturer and distributor of in vitro diagnostics, reagents, and laboratory equipment. The contract is for in vitro diagnostic reagents and supplies, and is not set-aside. Roche Diagnostics has previously held multiple General Services Administration (GSA) Schedule contracts and Indefinite...
- Invitro Diagnostics, Reagents, Test (FSS-65-VII)Master GSA Schedule
- 36F79722D0128Federal Supply Schedule
- 36F79722D0128-36C25724N0385Delivery Order
This federal contract award to Roche Diagnostics Corporation, doing business as Roche Diagnostics Corp, is for the delivery of ACCU-CHECK INFORM II glucose control and solutions. The contract, valued at $326,460.00, is a firm fixed price delivery order awarded by the Veterans Integrated Service Network 17 (VISN 17) of the U.S. Department of Veterans Affairs. The award has an ultimate completion date of June 30, 2029. Roche Diagnostics is providing these medical devices and supplies through its General Services Administration (GSA) Schedule contract for in vitro diagnostics, reagents, and test kits. The contract does not have a set-aside designation. As a prime contractor, Roche Diagnostics has a history of providing critical care analyzers, reagents, test kits, and associated equipment, supplies, and services to various federal agencies, including the VA, Department of Defense, and Department of Health and Human Services, to support healthcare delivery for veterans, active duty military, and other eligible patients.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| P00002 | Exercise an Option | $65.3k | 3/17/25 | |
| Not listed | Not listed | $65.3k | 7/3/24 |